Novel hemorrhagic stroke therapy bests medical management
Publish date: February 11, 2013
AT THE INTERNATIONAL STROKE CONFERENCE
The MISTIE trial was funded by the National Institute of Neurological Disorders and Stroke. Dr. Hanley reported having no relevant financial conflicts.
